Northwest Investment Counselors’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-17
Closed 626
2022
Q1
$0 Buy
+17
New +$466 ﹤0.01% 632

Northwest Investment Counselors's XENT Position: Q2 2022 in Review

Northwest Investment Counselors sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 17 shares.

Northwest Investment Counselors first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Northwest Investment Counselors reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Northwest Investment Counselors sold 17 Intersect ENT, Inc shares in Q2 2022.
  • Northwest Investment Counselors first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • Northwest Investment Counselors's Intersect ENT, Inc position peaked at $0 in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Northwest Investment Counselors's 13F filing for Q2 2022, filed 26 Jul 2022.